Cargando…

Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo

Uveal melanoma is a rare but often lethal malignancy and is the leading cause of death due to an ophthalmic condition. Uveal melanoma is often diagnosed at a late stage and has a strong propensity to hepatic metastasis. Recently, the most common driver mutations in uveal melanoma have been identifie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Musi, Elgilda, Schwartz, Gary K., Yoo, Jae Hyuk, Odelberg, Shannon J., Li, Dean Y., Bonner, Michael Y., Selvakumar, Ponniah, Rao, Shikha, Gilbert, Linda C., Elsey, Justin, Arbiser, Jack L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633893/ https://www.ncbi.nlm.nih.gov/pubmed/31320995 http://dx.doi.org/10.18632/oncotarget.27040

Ejemplares similares

BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells
por: Ambrosini, Grazia, et al.
Publicado: (2015)

Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model
por: Díaz, Begoña, et al.
Publicado: (2016)

MITF deficiency accelerates GNAQ-driven uveal melanoma
por: Phelps, Grace B., et al.
Publicado: (2022)

The GPER Agonist LNS8801 Induces Mitotic Arrest and Apoptosis in Uveal Melanoma Cells
por: Ambrosini, Grazia, et al.
Publicado: (2023)

Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi
por: Van Raamsdonk, Catherine D., et al.
Publicado: (2008)

Oncogenic GNAQ and GNA11 Mutations in Uveal Melanoma in Chinese
por: Xu, Xiaolin, et al.
Publicado: (2014)

Mutation spectrum in GNAQ and GNA11 in Chinese uveal melanoma
por: Zhang, Edward D, et al.
Publicado: (2019)

Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma
por: Bauer, J, et al.
Publicado: (2009)

Mouse models of uveal melanoma: Strengths, weaknesses, and future directions
por: Richards, Jackson R., et al.
Publicado: (2020)

Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype
por: Ho, Alan L., et al.
Publicado: (2012)

Palladium based nanoparticles for the treatment of advanced melanoma
por: Elsey, Justin, et al.
Publicado: (2019)

Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11
por: Koopmans, A E, et al.
Publicado: (2013)

YAP inhibition blocks uveal melanogenesis driven by GNAQ or GNA11 mutations
por: Lyubasyuk, Vera, et al.
Publicado: (2014)

Introduction of Mutant GNAQ into Endothelial Cells Induces a Vascular Malformation Phenotype with Therapeutic Response to Imatinib
por: Sasaki, Maiko, et al.
Publicado: (2022)

Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma?
por: van Weeghel, Christiaan, et al.
Publicado: (2019)

GNAQ and GNA11 Genes: A Comprehensive Review on Oncogenesis, Prognosis and Therapeutic Opportunities in Uveal Melanoma
por: Silva-Rodríguez, Paula, et al.
Publicado: (2022)

Lack of GNAQ and GNA11 Germ-Line Mutations in Familial Melanoma Pedigrees with Uveal Melanoma or Blue Nevi
por: Hawkes, Jason E., et al.
Publicado: (2013)

Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism
por: de Lange, Mark J., et al.
Publicado: (2015)

Case Report: GNAQ- and SF3B1 Mutations in an Aggressive Case of Relapsing Uveal Ring Melanoma
por: Prasuhn, Michelle, et al.
Publicado: (2022)

Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma
por: Metz, Claudia HD, et al.
Publicado: (2013)

Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations
por: Boru, Getachew, et al.
Publicado: (2019)

Establishment of a Temperature-Sensitive Model of Oncogene-Induced Senescence in Angiosarcoma Cells
por: da Costa, Adilson, et al.
Publicado: (2020)

Correction: da Costa et al. Establishment of a Temperature-Sensitive Model of Oncogene-Induced Senescence in Angiosarcoma Cells. Cancers 2020, 12, 395
por: da Costa, Adilson, et al.
Publicado: (2021)

Tris DBA ameliorates IgA nephropathy by blunting the activating signal of NLRP3 inflammasome through SIRT1‐ and SIRT3‐mediated autophagy induction
por: Wu, Chung‐Yao, et al.
Publicado: (2020)

Misaligned sequencing reads from the GNAQ-pseudogene locus may yield GNAQ artefact variants
por: Lim, Jing Quan, et al.
Publicado: (2022)

Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target
por: Bao, Riyue, et al.
Publicado: (2020)

Tris(dibenzylideneacetone)dipalladium(0) (Tris DBA) Abrogates Tumor Progression in Hepatocellular Carcinoma and Multiple Myeloma Preclinical Models by Regulating the STAT3 Signaling Pathway
por: Arora, Loukik, et al.
Publicado: (2021)

Minimal contribution of ERK1/2-MAPK signalling towards the maintenance of oncogenic GNAQ(Q209P)-driven uveal melanomas in zebrafish
por: Mouti, Mai Abdel, et al.
Publicado: (2016)

High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma
por: Arang, Nadia, et al.
Publicado: (2023)

A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma
por: Shoushtari, Alexander N., et al.
Publicado: (2021)

Significant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma
por: Patwardhan, Parag P., et al.
Publicado: (2015)

DBA Survivor
por: LaRock, Thomas
Publicado: (2010)

miR-142-3p suppresses uveal melanoma by targeting CDC25C, TGFβR1, GNAQ, WASL, and RAC1
por: Peng, Dewei, et al.
Publicado: (2019)

Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma
por: Dono, M, et al.
Publicado: (2014)

trans-Dibromidobis[tris(4-chlorophenyl)phosphine]palladium(II)
por: Kirsten, Leo, et al.
Publicado: (2009)

trans-Dichloridobis[tris(2-methoxyphenyl)phosphine]palladium(II)
por: van Blerk, Charmaine, et al.
Publicado: (2009)

Mutational Profile of GNAQ (Q209) in Human Tumors
por: Lamba, Simona, et al.
Publicado: (2009)

Gnaq and Gna11 in the Endothelin Signaling Pathway and Melanoma
por: Urtatiz, Oscar, et al.
Publicado: (2016)

GNAQ mutation in a patient with metastatic mucosal melanoma
por: Kim, Chung-Young, et al.
Publicado: (2014)

BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi
por: Francis, Jasmine H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7c8jk8jr4os4ebpmh89qv6sj21